logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study

Bastard M, Sanchez-Padilla E, du Cros PAK, Khamraev AK, Parpieva N, Tillyashaykhov M, Hayrapetyan A, Kimenye K, Khurkhumal S, Dlamini T, Perez SF, Telnov A, Hewison CCH, Varaine FFV, Bonnet MMB
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
The emergence of resistance to anti-tuberculosis (DR-TB) drugs and the HIV epidemic represent a serious threat for reducing the global burden of TB. Although data on HIV-negative DR-TB treatment outcomes are well published, few data on DR-TB outcomes among HIV co-infected people is available despite the great public health importance.

Countries

Armenia Colombia Georgia Kenya Kyrgyzstan Uzbekistan

Subject Area

tuberculosisHIV/AIDS

Languages

English
DOI
10.1371/journal.pone.0193491
Published Date
08 Mar 2018
PubMed ID
29518098
Journal
PLOS One
Volume | Issue | Pages
Volume 13, Issue 3
Issue Date
2018-03-08
Dimensions Badge